Latest Regulatory Approvals News

Actinogen Medical has enrolled its 100th participant in the XanaMIA phase 2b/3 Alzheimer’s trial, setting the stage for a critical interim analysis in January 2026 and final results by year-end.

ECS Botanics has launched the globally acclaimed Terphogz™ cannabis strains, including The Original Z™, into the Australian medicinal market, marking a strategic expansion of its premium product portfolio.

Estrella Resources has confirmed a $5 million capital injection from a strategic investor exercising a tranche subscription option, underpinning its ambitious manganese and limestone projects in Timor-Leste.

Dimerix Limited has received a significant milestone payment from its Japanese partner FUSO Pharmaceutical, marking progress in the Phase 3 clinical trial of DMX-200 for kidney disease. This payment underscores the growing momentum behind Dimerix’s global licensing strategy.

Brightstar Resources has completed a Definitive Feasibility Study for its Menzies and Laverton Gold Projects, outlining a robust staged development plan with strong financial returns and a targeted final investment decision in 2025.

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.

Peak Rare Earths has satisfied a critical Tanzanian mining licence condition and secured regulatory consent, advancing its proposed acquisition by a Shenghe subsidiary. The deal still awaits shareholder and further regulatory approvals.

Battery Age Minerals has secured its first drilling permit for the Bleiberg Zinc-Germanium Project in Austria, setting the stage for exploration at one of Europe’s richest germanium sources amid tightening global supply.

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.

Santos Limited has entered a process deed granting XRG Consortium exclusive rights to pursue a potential A$8.89 per share cash takeover offer, setting the stage for a pivotal chapter in the oil and gas sector.

Assetora Australia Limited has been officially appointed as the Responsible Entity of the DomaCom Fund, lifting previous restrictions and paving the way for renewed investment activity and secondary market trading.

Silk Logistics Holdings and DP World Australia have agreed to push back the deadline for their acquisition deal, awaiting a key regulatory decision from the ACCC.